发明人唐晓军,高志强,胡光. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 112163080 A, 授权公告日 2019-12-13.
发明人张德明,徐明华,罗永刚. "Method for the Synthesis of 3-Isobutyl-5-((3-(4-methoxy-2-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one" [P]. 中国发明专利, 专利号 CN 115045697 A, 授权公告日 2017-05-25.
发明人郭海燕,罗永刚,周伟. "A Process for Preparing High-Purity 3-Isobutyl-5-((3-(4-methoxy-2-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one" [P]. 中国发明专利, 专利号 CN 117373067 B, 授权公告日 2022-02-19.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2019, 958, 6955-6980.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2012, 1377, (7), 7421-7448.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 3-Isobutyl-5-((3-(4-methoxy-2-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one Using HRMS and NMR". Anal. Chim. Acta, 2012, 845, (9), 5591-5612.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 1965, 463-468.